- Home
- GERN vs NSSC Comparison
GERN vs NSSC Comparison
Compare GERN & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- NSSC
- Stock Information
- Founded
- GERN 1990
- NSSC 1969
- Country
- GERN United States
- NSSC United States
- Employees
- GERN N/A
- NSSC N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- NSSC Telecommunications Equipment
- Sector
- GERN Health Care
- NSSC Telecommunications
- Exchange
- GERN Nasdaq
- NSSC Nasdaq
- Market Cap
- GERN 853.5M
- NSSC 899.1M
- IPO Year
- GERN 1996
- NSSC N/A
- Fundamental
- Price
- GERN $1.57
- NSSC $27.90
- Analyst Decision
- GERN Buy
- NSSC Strong Buy
- Analyst Count
- GERN 9
- NSSC 4
- Target Price
- GERN $5.13
- NSSC $33.75
- AVG Volume (30 Days)
- GERN 13.0M
- NSSC 502.3K
- Earning Date
- GERN 05-07-2025
- NSSC 05-05-2025
- Dividend Yield
- GERN N/A
- NSSC 2.01%
- EPS Growth
- GERN N/A
- NSSC N/A
- EPS
- GERN N/A
- NSSC 1.22
- Revenue
- GERN $116,293,000.00
- NSSC $181,227,000.00
- Revenue This Year
- GERN $160.12
- NSSC N/A
- Revenue Next Year
- GERN $55.01
- NSSC $6.02
- P/E Ratio
- GERN N/A
- NSSC $22.86
- Revenue Growth
- GERN 22264.04
- NSSC N/A
- 52 Week Low
- GERN $1.17
- NSSC $19.00
- 52 Week High
- GERN $5.34
- NSSC $58.09
- Technical
- Relative Strength Index (RSI)
- GERN 51.71
- NSSC 68.23
- Support Level
- GERN $1.30
- NSSC $27.67
- Resistance Level
- GERN $1.54
- NSSC $28.59
- Average True Range (ATR)
- GERN 0.11
- NSSC 0.60
- MACD
- GERN 0.03
- NSSC -0.07
- Stochastic Oscillator
- GERN 66.67
- NSSC 59.65
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.